U.K.’s MHRA Moves To Implement Restrictions On Prexige Prescribing
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis issues “Dear Healthcare Professional” letter advising physicians to conduct regular liver function tests on patients using the COX-2 inhibitor.